DE3921211C1 - - Google Patents

Info

Publication number
DE3921211C1
DE3921211C1 DE19893921211 DE3921211A DE3921211C1 DE 3921211 C1 DE3921211 C1 DE 3921211C1 DE 19893921211 DE19893921211 DE 19893921211 DE 3921211 A DE3921211 A DE 3921211A DE 3921211 C1 DE3921211 C1 DE 3921211C1
Authority
DE
Germany
Prior art keywords
cells
cell precursors
antigen
medium
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19893921211
Other languages
German (de)
English (en)
Inventor
Des Erfinders Auf Nennung Verzicht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDT AG fur IN VIVO DIAGNOSTIK und THERAPIE ZUERICH CH
Original Assignee
IDT AG fur IN VIVO DIAGNOSTIK und THERAPIE ZUERICH CH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDT AG fur IN VIVO DIAGNOSTIK und THERAPIE ZUERICH CH filed Critical IDT AG fur IN VIVO DIAGNOSTIK und THERAPIE ZUERICH CH
Priority to DE19893921211 priority Critical patent/DE3921211C1/de
Priority to EP19900909725 priority patent/EP0431125A1/de
Priority to PCT/EP1990/000976 priority patent/WO1991000342A1/de
Priority to CA 2033984 priority patent/CA2033984A1/en
Application granted granted Critical
Publication of DE3921211C1 publication Critical patent/DE3921211C1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19893921211 1989-06-28 1989-06-28 Expired - Lifetime DE3921211C1 (https=)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19893921211 DE3921211C1 (https=) 1989-06-28 1989-06-28
EP19900909725 EP0431125A1 (de) 1989-06-28 1990-06-20 Herstellungsverfahren fur humane monoklonale antikörper
PCT/EP1990/000976 WO1991000342A1 (de) 1989-06-28 1990-06-20 Herstellungsverfahren fur humane monoklonale antikörper
CA 2033984 CA2033984A1 (en) 1989-06-28 1990-06-20 Method for the production of human monoclonal antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19893921211 DE3921211C1 (https=) 1989-06-28 1989-06-28

Publications (1)

Publication Number Publication Date
DE3921211C1 true DE3921211C1 (https=) 1990-11-29

Family

ID=6383797

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19893921211 Expired - Lifetime DE3921211C1 (https=) 1989-06-28 1989-06-28

Country Status (4)

Country Link
EP (1) EP0431125A1 (https=)
CA (1) CA2033984A1 (https=)
DE (1) DE3921211C1 (https=)
WO (1) WO1991000342A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042837A (en) * 1989-09-20 2000-03-28 Kalland; Terje Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
US6197299B1 (en) 1990-07-20 2001-03-06 Pharmacia & Upjohn Ab Antibody conjugates
EP0523949B1 (en) * 1991-07-15 2003-06-25 The Wellcome Foundation Limited Production of antibodies
GB9126094D0 (en) * 1991-12-09 1992-02-12 Immune Systems Ltd In vitro antibody production
SE9601245D0 (sv) 1996-03-29 1996-03-29 Pharmacia Ab Chimeric superantigens and their use
TW517061B (en) 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811692A1 (de) * 1988-04-07 1989-10-19 Idt Ag Fuer In Vivo Diagnostik Diagnostikverfahren und mittel zur diagnose und behandlung immunologischer erkrankungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444887A (en) * 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4693966A (en) * 1983-03-11 1987-09-15 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies from lymphocytes of patients with malignant melanoma
JPH02502424A (ja) * 1987-03-11 1990-08-09 ザ・チルドレンズ・ホスピタル，インコーポレイテッド 抗原特異的ｔセルラインの調製法並びに治療のためのその使用
DE3827145A1 (de) * 1987-12-03 1989-06-15 Biotechnolog Forschung Gmbh Monoklonale antikoerper, hybridoma-zellinien zur gewinnung der antikoerper, verfahren zur gewinnung der antikoerper und der zellinien, sowie verwendung der antikoerper

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811692A1 (de) * 1988-04-07 1989-10-19 Idt Ag Fuer In Vivo Diagnostik Diagnostikverfahren und mittel zur diagnose und behandlung immunologischer erkrankungen

Also Published As

Publication number Publication date
WO1991000342A1 (de) 1991-01-10
EP0431125A1 (de) 1991-06-12
CA2033984A1 (en) 1990-12-29

Similar Documents

Publication Publication Date Title
DE3280462T2 (de) Antikörper gegen eine Zusammensetzung mit Mediatoraktivität und seine Verwendung in einer pharmazeutischen Zusammensetzung.
DE69328481T2 (de) In vitro bildung von dentritischen zellen
DE3588082T2 (de) Verfahren und zusammensetzungen zur verwendung in der diagnose und behandlung autoimmuner krankheiten
EP1257290A2 (de) Verfahren zur antigen-spezifischen stimulation von t-lymphozyten mit synthetischen peptidbibliotheken
EP0584715B1 (de) Verfahren zur Isolierung und Kultivierung von transformierten Zellen sowie Verwendung dieser Zellen zur Herstellung individuumsspezifischer Antikörper
DE3650676T2 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
DE3889138T2 (de) Influenza-Impfstoff.
DE3921211C1 (https=)
EP0279460A1 (de) Virusantigen, Verfahren zu seiner Gewinnung und Anwendung in Diagnose und Therapie (Impfstoff)
DE68925660T2 (de) Peptidfragmente von HIV
Goldstein et al. Loss of reactivity of HL-A antigens in clonal populations of cultured human fibroblasts during aging in vitro
EP0955361A1 (de) Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstelung sowie ihre Verwendung
Dickinson Experiments on the physiology and genetics the smut fungi.—Hyphal-fusion
Daniel et al. Herpesvirus saimiri. III. Plaque formation under multi agar, methyl cellulose and starch overlays
DE3413339A1 (de) Gegen pilze der gattung candida gerichtete antikoerper
DE3750151T2 (de) Verwendung von aktivierten T-Lymphozyten zur Vorbereitung einer pharmazeutischen Zusammensetzung zur Behandlung von AIDS.
DE69011898T2 (de) Gegen menschlichen Papillomavirus monoklonaler Antikörper, Hybridom, das ihn produziert, und Verfahren zur Herstellung.
Nagel et al. Human B cell function in normal individuals of various ages. 1. In vitro enumeration of pokeweed-induced peripheral blood lymphocyte immunoglobulin-synthesizing cells and the comparison of the results with numbers of peripheral B and T cells, mitogen responses, and levels of serum immunoglobulins
Twarog et al. Cellular identification of β-lactoglobulin synthesis in bovine mammary cell cultures
Landreth et al. Deficiency in cells expressing terminal transferase in autoimmune (motheaten) mice
McMillan et al. The developmental history of the plasmacyte
Ishimaru et al. An electron microscopic study of tumour cell adhesiveness induced by aggregation promoting factor from rat ascites hepatoma cells
DE3628718A1 (de) Geloeste interleukin-2-rezeptoren als indikator fuer immunreaktionen und neoplasien
DE69917964T2 (de) Gegen Mast-Zellen der Bindegeweben gerichteter Antikörper und Hybridomen zur Produktion dieser Antikörper
DE3705512C2 (https=)

Legal Events

Date Code Title Description
8100 Publication of the examined application without publication of unexamined application
D1 Grant (no unexamined application published) patent law 81
8363 Opposition against the patent
8330 Complete disclaimer